The article sheds light on preliminary injunction proceedings before the local division of the Unified Patent Court (UPC) in Munich between the applicant Tiroler Rohre (TRM) and the defendants SSAB Swedish Steel GmbH and SSAB Europe Oy concerning pile shoes for anchoring str...
Continue reading
Generic drug companies have successfully challenged two key Novo Nordisk patents related to the tablet formulation of semaglutide, a blockbuster drug for diabetes (Rybelsus) and weight loss (Wegovy). The European Patent Office’s Boards of Appeal revoked patents EP 2 827 84...
Continue reading
In the ongoing case between Sanofi and the generic drug manufacturer Accord, the Paris Judicial Court has fully revoked Sanofi’s patent for the chemotherapy drug Jevtana. The patent EP 2 493 466, which protects a new use of cabazitaxel in combination with prednisone or pre...
Continue reading
All press coverage
We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...
Continue reading
Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...
Continue reading
Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...
Continue reading
All press releases
Partner
German Patent Attorney
European Patent Attorney
UPC Representative
Chemist